Evidence map›Paper›PMID 32792862›Full record

ArticleInternational journal of biological sciences2020

Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis

Yen-Ta Chen, Chi-Ruei Huang, Chia-Lo Chang, John Y Chiang, Chi-Wen Luo, Hong-Hwa Chen, Hon-Kan Yip

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Use of Melatonin in Cancer Treatment: Where Are We?International journal of molecular sciences · 2022
    Review
  12. Notch signaling pathway: architecture, disease, and therapeutics.Signal transduction and targeted therapy · 2022
    Review
  13. Components ofJournal of oncology · 2022
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yen-Ta ChenDivision of Urology, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chi-Ruei HuangCenter for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Chia-Lo ChangDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
John Y ChiangDepartment of Computer Science and Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Chi-Wen LuoDepartment of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hong-Hwa ChenDivision of Colorectal Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Hon-Kan YipCenter for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Chang Gung University · TWKaohsiung Chang Gung Memorial Hospital · TWKaohsiung Medical University · TWAsia University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntioxidantsCarcinomaCell Line, TumorDrug Screening Assays, AntitumorHumansJagged-2 ProteinMaleMatrix MetalloproteinasesMelatoninMice, NudePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, NotchTOR Serine-Threonine KinasesUrinary Bladder NeoplasmsAntioxidantsJAG2 protein, humanJagged-2 ProteinMatrix MetalloproteinasesMelatoninMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, NotchTOR Serine-Threonine Kinasesbladder cancercell-stress signalingmatrix metalloproteinasesNotch/Jagged2

Identifiers

PMID32792862
PMCPMC7415428
OpenAlexW3044100825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.